Search - tctmd.com

Displaying 61 - 80 of 163

Sort: Relevancy | Date

News Daily News

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

Caitlin E. Cox

September 05, 2018

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Conference News CRT 2018

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Michael O'Riordan

March 08, 2018

Presentation JIM 2018

The Synergy Stent in High Risk Patients: Why Design Matters

Presenter: Giulio G. Stefanini

February 23, 2018

News Industry News

Corindus to Co-Sponsor Courses at Multiple Leading Healthcare Institutions on Value-based Interventional Procedural Training

January 24, 2018

Presentation Cardiovascular Interventions 2017

BP-DES Update: SYNERGY and Beyond

Presenter: Dean J. Kereiakes

November 10, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

Presentation TCT 2017

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Presenter: Ioannis Iakovou, Gert Richardt, Dean J. Kereiakes

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

Presenter: C. Michael Gibson, Stephan Windecker

October 30, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Industry News

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

August 26, 2017

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

Presentation TVT 2017

Transcatheter Mitral Valve Replacement vs Repair: Competition or Synergy

Presenter: John G. Webb, Robert L. Smith

June 16, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Conference News EAS 2017

Is Atherosclerosis an LDL-Cholesterol or Immune Disease? The Answer May Be Both

Yael L. Maxwell

April 25, 2017

Presentation SIF 2017

BP-DES Update: SYNERGY and Beyond

Presenter: Dean J. Kereiakes

March 10, 2017

Presentation JIM 2017

The Synergy Stent: Optimal Healing in Complex Patients

Presenter: Robert A. Byrne

February 10, 2017

Advertisement

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

The Synergy Stent in High Risk Patients: Why Design Matters

Corindus to Co-Sponsor Courses at Multiple Leading Healthcare Institutions on Value-based Interventional Procedural Training

BP-DES Update: SYNERGY and Beyond

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Off Script: Focusing on the Future

Expanding Clinical Evidence With SYNERGY: From EVOLVE II to Real-world Registries and EVOLVE DAPT

Predicting The Future: Will the Ongoing DES 3-Month DAPT Studies With Synergy and Xience Change How We Treat High Risk Bleeding Patients?

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

Boston Scientific Scraps Biodegradable Scaffold Program

Transcatheter Mitral Valve Replacement vs Repair: Competition or Synergy

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Is Atherosclerosis an LDL-Cholesterol or Immune Disease? The Answer May Be Both

BP-DES Update: SYNERGY and Beyond

The Synergy Stent: Optimal Healing in Complex Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content